Sanara MedTech (NASDAQ:SMTI) and Envoy Medical (NASDAQ:COCH) Critical Contrast

Sanara MedTech (NASDAQ:SMTI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings for Sanara MedTech and Envoy Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	0	0	1	0	3.00
Envoy Medical	0	0	2	0	3.00

Sanara MedTech currently has a consensus target price of $44.00, indicating a potential upside of 36.60%. Envoy Medical has a consensus target price of $6.00, indicating a potential upside of 18.34%. Given Sanara MedTech’s higher possible upside, equities research analysts clearly believe Sanara MedTech is more favorable than Envoy Medical.

Risk & Volatility

Sanara MedTech has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.68, suggesting that its stock price is 168% more volatile than the S&P 500.

Earnings & Valuation

This table compares Sanara MedTech and Envoy Medical’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$64.99 million	4.27	-$4.30 million	($0.52)	-61.94
Envoy Medical	$320,000.00	310.54	-$29.91 million	N/A	N/A

Sanara MedTech has higher revenue and earnings than Envoy Medical.

Profitability

This table compares Sanara MedTech and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-6.62%	-11.12%	-7.11%
Envoy Medical	N/A	N/A	-100.39%

Insider & Institutional Ownership

8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 55.2% of Sanara MedTech shares are owned by company insiders. Comparatively, 0.7% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Envoy Medical beats Sanara MedTech on 6 of the 11 factors compared between the two stocks.

About Sanara MedTech

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.